Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 2, 2009, Pages 155-162

  Sakuma, Masae ^a   Arai, Hidekazu ^a,b   Mizuno, Akira ^a   Fukaya, Makiko ^a   Matsuura, Motoi ^c   Sasaki, Hajime ^c   Yamanaka Okumura, Hisami ^a   Yamamoto, Hironori ^a   Taketani, Yutaka ^a   Doi, Toshio ^a   Takeda, Eiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

8 hydroxydeoxyguanosine; Glucose metabolism; HbA1c; Palatinose; Postprandial hyperglycemia

Indexed keywords

DEXTRIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PALATINOSE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LONG TERM CARE; LONG TERM EXPOSURE; MALE; MEAL; POSTPRANDIAL STATE;

EID: 70350334557     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-08     Document Type: Article

References (44)

1. Harris, M.I.: Diabetes in America: epidemiology and scope of the problem. Diabetes Care, 21 Suppl 3, C11-C14, 1998.
2. Avignon, A., Radauceanu, A., and Monnier, L.: Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care, 20, 1822-1826, 1997.
3. rd, Stuart, C.A., Brodows, R.G., Schwartz, S., Graf, C.J., Zagar, A., and Robertson, K.E.: Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group. Diabetes Care, 23, 1236-1241, 2000.
4. de Veciana, M., Major, C.A., Morgan, M.A., Asrat, T., Toohey, J.S., Lien, J.M., and Evans, A.T.: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N. Engl. J. Med., 333, 1237-1241, 1995.
5. McCance, D.R., Hanson, R.L., Charles, M.A., Jacobsson, L.T., Pettitt, D.J., Bennett, P.H., and Knowler, W.C.: Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ, 308, 1323-1328, 1994.
6. Engelgau, M.M., Thompson, T.J., Herman, W.H., Boyle, J.P., Aubert, R.E., Kenny, S.J., Badran, A., Sous, E.S., and Ali, M.A.: Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care, 20, 785-791, 1997.
7. Lowe, L.P., Liu, K., Greenland, P., Metzger, B.E., Dyer, A.R., and Stamler, J.: Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care, 20, 163-169, 1997.
8. Donahue, R.P., Abbott, R.D., Reed, D.M., and Yano, K.: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes, 36, 689-692, 1987.
9. Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H.J., and Lindner, J.: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia, 39, 1577-1583, 1998. (Pubitemid 26397370)
10. Balkau, B., Shipley, M., Jarrett, R.J., Pyörälä, K., Pyörälä, M., Forhan, A., and Eschwège, E.: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care, 21, 360-367, 1998.
11. DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med., 121, 397-405, 2001.
12. Nakagami, T.; DECODA Study Group: Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia, 47, 385-394, 2004.
13. Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., and Sekikawa, A.: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care, 22, 920-924, 1999.
14. Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A., and Laakso, M.: STOP-NIDDM Trial Research Group.: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA, 290, 486-494, 2003.
15. Jenkins, D.J., Wolever, T.M., Taylor, R.H., Barker, H., Fielden, H., Baldwin, J.M., Bowling, A.C., Newman, H.C., Jenkins, A.L., and Goff, D.V.: Glycemic index of foods: a physiological basis for carbohydrate exchange. Am. J. Clin. Nutr., 34, 362-366, 1981.
16. Salmeron, J., Ascherio, A., Rimm, E.B., Colditz, G.A., Spiegelman, D., Jenkins, D.J., Stampfer, M.J., Wing, A.L., and Willett, W.C.: Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care, 20, 545-550, 1997.
17. Meyer, K.A., Kushi, L.H., Jacobs, D.R. Jr., Slavin, J., Sellers, T.A., and Folsom, A.R.: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am. J. Clin. Nutr., 71, 921-930, 2000.
18. Brand, J.C., Colagiuri, S., Crossman, S., Allen, A., Roberts, D.C., and Truswell, A.S.: Low-glycemic index foods improve long-term glycemic control in NIDDM. Diabetes Care, 40, 95-101, 1991.
19. Fontvieille, A.M., Rizkalla, S.W., Penfornis, A., Acosta, M., Bornet, F.R., and Slama, G.: The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks. Diabet. Med., 9, 444-450, 1992.
20. Behall, K.M. and Howe, J.C.: Effect of long-term consumption of amylose vs amylopectin starch on metabolic variables in human subjects. Am. J. Clin. Nutr., 61, 334-340, 1999.
21. Järvi, A.E., Karlström, B.E., Granfeldt, Y.E., Björck, I.E., Asp, N.G., and Vessby, B.O.: Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care, 22, 10-18, 1999.
22. Nestler, J.E., Gebhart, S.S., and Blackard, W.G.: Failure of a midnocturnal insulin infusion to suppress the increased insulin need for breakfast in insulin-dependent diabetic patients. Diabetes, 33, 266-270, 1984.
23. Vlachokosta, F.V., Piper, C.M., Gleason, R., Kinzel, L., and Kahn, C.R.: Dietary carbohydrate, a Big Mac, and insulin requirements in type I diabetes. Diabetes Care, 11, 330-336, 1988. (Pubitemid 18195623)
24. Boden, G., Chen, X., and Urbain, J.L.: Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes, 45, 1044-1050, 1996. (Pubitemid 26260156)
25. Siddiqui, I.R. and Furgala, B.: Isolation and characterization of oligosaccharides from honey. Part 1. Disaccharides. J. Apic. Res., 6, 139-145, 1967.
26. Lina, B.A., Jonker, D., and Kozianowski, G.: Isomaltulose (Palatinose): a review of biological and toxicological studies. Food Chem. Toxico., 40, 1375-1381, 2002.
27. Okuda, Y., Kawai, K., Chiba, Y., Koide, Y., and Yamashita, K.: Effects of parenteral palatinose on glucose metabolism in normal and streptozotocin diabetic rats. Horm. Metab. Res., 18, 361-364, 1986.
28. Kawai, K., Yoshikawa, H., Murayama, Y., Okuda, Y., and Yamashita, K.: Usefulness of palatinose as a caloric sweetener for diabetic patients. Horm. Metab. Res., 21, 338-340, 1989.
29. Arai, H., Mizuno, A., Sakuma, M., Fukaya, M., Matsuo, K., Muto, K., Sasaki, H., Matsuura, M., Okumura, H., Yamamoto, H., Taketani, Y., Doi, T., and Takeda, E.: Effects of a palatinose-based liquid diet (Inslow®) on glycemic control and the second-meal effect in healthy men. Metabolism, 56, 115-121, 2007.
30. Arai, H., Mizuno, A., Matsuo, K., Fukaya, M., Sasaki, H., Arima, H., Matsuura, M., Taketani, Y., Doi, T., and Takeda, E.: Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism, 53, 977-983, 2004. (Pubitemid 38988279)
31. Wolever, T.M., Jenkins, D.J., Vuksan, V., Jenkins, A.L., Buckley, G.C., Wong, G.S., and Josse, R.G.: Beneficial effect of a low glycaemic index diet in type 2 diabetes. Diabet. Med., 9, 451-458, 1992.
32. Golay, A., Koellreutter, B., Bloise, D., Assal, J.P., and Würsch, P.: The effect of muesli or cornflakes at breakfast on carbohydrate metabolism in type 2 diabetic patients. Diabetes. Res. Clin. Pract., 15, 135-141, 1992.
33. Jenkins, D.J., Wolever, T.M., Taylor, R.H., Griffiths, C., Krzeminska, K., Lawrie, J.A., Bennett, C.M., Goff, D.V., Sarson, D.L., and Bloom, S.R.: Slow release dietary carbohydrate improves second meal tolerance. Am. J. Clin. Nutr., 35, 1339-1346, 1982.
34. Wolever, T.M., Jenkins, D.J., Ocana, A.M., Rao, V.A., and Collier, G.R.: Second-meal effect: low-glycemic-index foods eaten at dinner improve subsequent breakfast glycemic response. Am. J. Clin. Nutr., 48, 1041-1047, 1988.
35. Matsuo, K., Arai, H., Muto, K., Fukaya, M., Sato, T., Mizuno, A., Sakuma, M., Yamanaka-Okumura, H., Sasaki, H., Yamamoto, H., Taketani, Y., Doi, T., and Takeda, E.: The anty-obesity effect of palatinose-based formula Inslow® is likely due to an increase in the hepatic PPAR-α and adipocyte PPAR-γ gene expressions. J. Clin. Biochem. Nutr., 40, 234-241, 2007.
36. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., and Kadowaki, T.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 7, 941-946, 2001.
37. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B.B., and Kadowaki, T.: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med., 8, 1288-1295, 2002.
38. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., and Tataranni, P.A.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 86, 1930-1935, 2001.
39. Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D., and Nicotera, T.: Oxidative damage to DNA in diabetes mellitus. Lancet, 347, 444-445, 1996. (Pubitemid 26054071)
40. Hinokio, Y., Suzuki, S., Hirai, M., Chiba, M., Hirai, A., and Toyota, T.: Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia, 42, 150-152, 1999.
41. Leinonen, J., Lehtimäki, T., Toyokuni, S., Okada, K., Tanaka, T., Hiai, H., Ochi, H., Laippala, P., Rantalaiho, V., Wirta, O., Pasternack, A., and Alho, H.: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett., 417, 150-152, 1997. (Pubitemid 27490491)
42. Loft, S., Fischer-Nielsen, A., Jeding, I.B., Vistisen, K., and Poulsen, H.E.: 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health, 40, 391-404, 1993.
43. Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P., and Colette, C.: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295, 1681-1687, 2006.
44. Giugliano, D., Ceriello, A., and Paolisso, G.: Oxidative stress and diabetic vascular complications. Diabetes Care, 19, 257-267, 1996. (Pubitemid 26070354)